IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Iradimed (NASDAQ: IRMD) announced that President and CEO Roger Susi and CFO Jack Glenn will attend the Goldman Sachs 47th Annual Global Healthcare Conference, held June 8–10, 2026, at the Loews Miami Beach Hotel in Miami Beach, Florida.

Rhea-AI Summary

Iradimed (NASDAQ: IRMD) announced that President and CEO Roger Susi and CFO Jack Glenn will attend the Goldman Sachs 47th Annual Global Healthcare Conference, held June 8–10, 2026, at the Loews Miami Beach Hotel in Miami Beach, Florida.

Interested investors can contact their Goldman Sachs representative to arrange one-on-one meetings with Iradimed management during the conference.

Argus May 20 session

+3.48% close to close Open Argus

Details

News Market Reaction – IRMD

On May 20, the day this news came out, IRMD closed 3.48% above the previous close.

Data tracked by StockTitan Argus for the May 20 session.

Market Context

This announcement highlights IRADIMED’s continued investor outreach, with senior management attendin...

Analysis

This announcement highlights IRADIMED’s continued investor outreach, with senior management attending the Goldman Sachs Global Healthcare Conference from June 8–10, 2026. It follows a series of strong earnings reports and multiple conference appearances in early 2026. Investors may focus on how management’s discussions at the event reinforce prior guidance, capital allocation—including the regular $0.20 dividend—and the commercial trajectory of its MRI-compatible device portfolio.

Key Figures

Conference number: 47th Conference dates: June 8–10, 2026

Conference number

47th

Goldman Sachs Annual Global Healthcare Conference edition

Conference dates

June 8–10, 2026

Scheduled dates of Goldman Sachs Global Healthcare Conference

Historical Context

5 past events · Latest: May 01

5 events

1. May 01

   Q1 2026 earnings

   24h Move

   +4.5%

   Reported Q1 2026 growth, record EPS, and reaffirmed full-year guidance.

2. Apr 27

   Earnings call notice

   24h Move

   +0.5%

   Announced timing and access details for Q1 2026 results call.

3. Apr 10

   Needham conference

   24h Move

   -2.3%

   Disclosed participation and one-on-one meetings at Needham virtual event.

4. Mar 16

   Roth conference

   24h Move

   +2.0%

   Announced management one-on-one meetings at Roth investor conference.

5. Feb 10

   FY 2025 earnings

   24h Move

   +9.6%

   Reported record Q4 and full-year 2025 results plus dividend increase.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

mri-compatible

1 terms

mri-compatible medical

"a leader in developing innovative MRI-compatible medical devices, today announced"

MRI-compatible describes a medical device, implant, or accessory that is safe to be placed in or near an MRI scanner and will not move, heat up, or interfere with the images produced by the machine. For investors, MRI compatibility is important because it expands a product’s usable market, reduces regulatory and liability risks, and can increase adoption by hospitals and patients — similar to making an electronic gadget that reliably works on any airline flight.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida.

Investors interested in meeting with Iradimed management during the conference may contact their Goldman Sachs representative to schedule a one-on-one meeting.

About IRADIMED CORPORATION

IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only known provider of a non-magnetic intravenous ("IV") infusion pump system specifically designed to be safe for use during MRI procedures. Our patented MRidium® MRI-compatible IV infusion pump systems and our 3880 MRI-compatible patient vital signs monitoring system are designed to enable accurate, safe, and dependable care before, during, and after MRI procedures. For more information, please visit www.iradimed.com. 

For more information, please visit www.iradimed.com.

Media Contact:
Jack Glenn
Chief Financial Officer
Iradimed Corporation
(407) 677-8022
InvestorRelations@iradimed.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Iradimed (NASDAQ: IRMD) attend the Goldman Sachs 47th Annual Global Healthcare Conference?

Iradimed will attend the Goldman Sachs 47th Annual Global Healthcare Conference from June 8–10, 2026. The event takes place at the Loews Miami Beach Hotel in Miami Beach, Florida, featuring meetings with company management.

Who will represent Iradimed (IRMD) at the Goldman Sachs 2026 Global Healthcare Conference?

Iradimed will be represented by President and CEO Roger Susi and Chief Financial Officer Jack Glenn. According to the company, both executives will be available for meetings with investors during the conference dates.

Where is the Goldman Sachs 47th Annual Global Healthcare Conference with Iradimed being held?

The Goldman Sachs 47th Annual Global Healthcare Conference will be held at the Loews Miami Beach Hotel in Miami Beach, Florida. Iradimed management plans to attend and meet with interested investors during the event.

How can investors schedule a one-on-one meeting with Iradimed (IRMD) at the Goldman Sachs healthcare conference?

Investors can schedule one-on-one meetings with Iradimed management by contacting their Goldman Sachs representative. According to the company, Goldman Sachs will coordinate meeting times during the June 8–10, 2026 conference.

Why is Iradimed (IRMD) participating in the Goldman Sachs 47th Annual Global Healthcare Conference?

Iradimed is participating to engage with investors and discuss its MRI-compatible medical device business. According to the company, management will be available for one-on-one meetings arranged through Goldman Sachs during the conference.